Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Horizon Pharma Plc

+ Add to Watchlist

HZNP:US

24.5900 USD 2.7800 12.75%

As of 10:29:28 ET on 03/30/2015.

Snapshot for Horizon Pharma Plc (HZNP)

Open: 25.2100 Day's Range: 24.5500 - 25.5000 Volume: 4,647,930
Previous Close: 21.8100 52wk Range: 7.8500 - 25.5000 1-Yr Rtn: +66.44%

Stock Chart for HZNP

No chart data available.
  • HZNP:US 24.7500
  • 1D
  • 1M
  • 1Y
21.8100
Interactive HZNP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for HZNP

Current P/E Ratio (ttm) 435.3728
Estimated P/E(12/2015) 17.2684
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) 0.0501
Est. EPS (USD) (12/2015) 1.2630
Est. PEG Ratio -
Market Cap (M USD) 2,881.86
Shares Outstanding (M) 132.13
30 Day Average Volume 3,238,759
Price/Book (mrq) 5.6601
Price/Sale (ttm) 6.9938
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/08/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HZNP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for HZNP

Horizon Pharma Plc is a holding company. The Company, through its subsidiaries, develops and commercializes late-stage biopharmaceutical therapies for the treatment of pain and inflammation.

Timothy P WalbertChairman/President/CEOPaul W HoelscherExec VP/CFO/Secretary
John J KodyExec VP/Chief Commercial OfcrRobert F Carey "Bob"Exec VP/Chief Business Officer
More Company Profile & Key Executives for HZNP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil